Spectrum Pharmaceuticals, Inc.
SPPI · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 54.4% | – | -100% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 93.2% | 82.3% | – | -7.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -26% | -107.1% | – | -73,951.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -32.9% | -88.4% | – | -74,474.4% |
| EPS Diluted | -0.026 | -0.049 | -0.12 | -0.17 |
| % Growth | 47.7% | 59.3% | 29.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |